ProSport Control - Step 2: Early follow-up at 1.5–2 months
ProSport Control – Step 2: Early Monitoring at 1.5–2 Months is the second stage of the sports monitoring program designed for both women and men who engage in regular physical activity and wish to evaluate how their body responds to training.
The package is recommended approximately 1.5–2 months after starting or increasing the intensity of a training program and allows monitoring of metabolic, hormonal, and functional changes associated with physical exercise.
The included tests help assess recovery processes, adaptation to training, hormonal status, and key factors affecting physical performance and overall health.
The results may help identify early signs of overtraining, insufficient recovery, and metabolic or hormonal imbalances, providing valuable information for adjusting training and nutrition strategies.
Indications
- 1.5–2 months after starting a training program;
- individuals who engage in regular physical activity and wish to monitor their progress;
- persistent fatigue or slow recovery after exercise;
- individuals following muscle-building or performance-oriented training programs;
- monitoring the body's response to dietary and lifestyle changes;
- prevention of overtraining and assessment of adaptation to physical exercise.
Package Contents
The package includes evaluation of:
- General health status and inflammatory processes (Complete Blood Count, ESR, C-Reactive Protein – CRP);
- Liver function and adaptation to regular physical activity (ALT, AST, Total Bilirubin);
- Lipid metabolism and cardiovascular risk (Total Cholesterol, LDL Cholesterol, HDL Cholesterol, Triglycerides, Homocysteine);
- Kidney function and protein metabolism (Estimated Glomerular Filtration Rate – eGFR CKD-EPI, Urea);
- Female and male hormonal balance (Prolactin, Total Estradiol, Calculated Free Testosterone);
- Muscle recovery and adaptation to training (IGF-1).
Procedure
The assessment involves collection of a venous blood sample.
Samples are collected by qualified healthcare professionals and analyzed using modern laboratory methods to evaluate changes associated with physical activity and recovery.
The average collection time is approximately 5–10 minutes.
Recovery / Restrictions
No special recovery measures are required after sample collection.
It is recommended to:
- maintain adequate hydration;
- avoid intense physical activity for several hours if discomfort occurs at the puncture site;
- follow the recommendations provided by medical staff.
Contraindications
There are no absolute contraindications to laboratory testing.
Testing may be temporarily postponed in cases of:
- acute infections accompanied by fever;
- acute illness or significantly impaired general condition;
- recent injuries or postoperative recovery;
- intense physical exertion within the previous 24–48 hours.
Advantages
- Monitoring of the body's adaptation to training;
- Assessment of recovery processes after physical exercise;
- Early detection of signs of overtraining;
- Monitoring of hormonal balance associated with regular physical activity;
- Evaluation of lipid metabolism and cardiovascular risk factors;
- Support for optimizing training and nutrition plans;
- Suitable for both women and men.
Preparation:
- Blood collection should be performed in the morning after 8–12 hours of fasting;
- Drinking still water is allowed;
- Intense exercise should be avoided for 24–48 hours before testing;
- Alcohol consumption is not recommended within 24 hours before testing;
- Sleep deprivation and significant physical or emotional stress should be avoided before sample collection;
- Any sports supplements, vitamins, minerals, or hormonal medications should be reported to medical staff.
Special Considerations for Men
For the most accurate hormonal assessment, blood collection is recommended during the first half of the day.
Special Considerations for Women
Since the package includes reproductive hormone testing (Estradiol, Prolactin), blood collection is recommended on days 2–5 of the menstrual cycle unless otherwise advised by a physician;
The use of hormonal contraceptives, pregnancy, or breastfeeding should be reported to medical staff before testing.